Cuban President Miguel Díaz-Canel today highlighted success of using the drug HeberFeron in reducing by eight times the frequency of basal cell carcinoma, a type of skin cancer.

Published in Health

Several patients receive the benefits of Heberferon, a Cuban medicine produced by the Genetic Engineering and Biotechnology Center (Cigb) to reduce or eliminate basal cell carcinoma, based on the combination of two products: Interferon Alfa 2 b with human gamma.

Published in Health

In 2017, more than 460 Cuban patients benefited from HeberFERON –a skin cancer medication, developed by the Havana-based Genetic Engineering and Biotechnology Center.

Published in Health